CIK: 0001400240 · Show all filings
Period: Q4 2021 (← Previous) (Next →)
Filing Date: Feb 14, 2022
Total Value ($000): $6,467,997 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MRNA | Moderna Inc | 17,581,016 | $4,465,227 | 69.0% | $16.43 | +1679.2% | COM | 60770K107 |
| SANA | Sana Biotechnology Inc | 34,239,018 | $530,020 | 8.2% | $32.56 | -40.8% | COM | 799566104 |
| — | Rubius Therapeutics Inc | 38,506,526 | $372,743 | 5.8% | $24.00 | — | COM | 78116T103 |
| — | Omega Therapeutics Inc | 25,902,269 | $293,473 | 4.5% | $18.85 | — | COM | 68217N105 |
| FHTX | Foghorn Therapeutics Inc | 12,674,120 | $289,857 | 4.5% | $19.16 | -25.0% | COM | 344174107 |
| — | Evelo Biosciences Inc | 23,030,069 | $139,793 | 2.2% | $10.39 | — | COM | 299734103 |
| — | Seres Therapeutics Inc | 14,378,802 | $119,774 | 1.9% | $8.55 | — | COM | 81750R102 |
| DNLI | Denali Therapeutics Inc | 2,619,968 | $116,851 | 1.8% | $17.97 | +163.6% | COM | 24823R105 |
| KLDO | Kaleido Biosciences Inc | 19,575,710 | $46,787 | 0.7% | $13.01 | -68.7% | COM | 483347100 |
| — | Codiak Biosciences Inc | 2,607,303 | $29,044 | 0.4% | $32.30 | — | COM | 192010106 |
| — | Sigilon Therapeutics Inc | 10,370,369 | $28,622 | 0.4% | $48.03 | — | COM | 82657L107 |
| — | Axcella Health Inc | 12,548,414 | $26,227 | 0.4% | $8.17 | — | COM | 05454B105 |
| — | Syros Pharmaceuticals Inc | 2,938,494 | $9,579 | 0.1% | $13.87 | — | COM | 87184Q107 |